1. Home
  2. ANVS vs RVP Comparison

ANVS vs RVP Comparison

Compare ANVS & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • RVP
  • Stock Information
  • Founded
  • ANVS 2008
  • RVP 1994
  • Country
  • ANVS United States
  • RVP United States
  • Employees
  • ANVS N/A
  • RVP N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • RVP Medical/Dental Instruments
  • Sector
  • ANVS Health Care
  • RVP Health Care
  • Exchange
  • ANVS Nasdaq
  • RVP Nasdaq
  • Market Cap
  • ANVS 24.2M
  • RVP 20.5M
  • IPO Year
  • ANVS 2020
  • RVP 2001
  • Fundamental
  • Price
  • ANVS $1.55
  • RVP $0.75
  • Analyst Decision
  • ANVS Strong Buy
  • RVP
  • Analyst Count
  • ANVS 4
  • RVP 0
  • Target Price
  • ANVS $40.67
  • RVP N/A
  • AVG Volume (30 Days)
  • ANVS 459.6K
  • RVP 38.0K
  • Earning Date
  • ANVS 05-20-2025
  • RVP 05-19-2025
  • Dividend Yield
  • ANVS N/A
  • RVP N/A
  • EPS Growth
  • ANVS N/A
  • RVP N/A
  • EPS
  • ANVS N/A
  • RVP N/A
  • Revenue
  • ANVS N/A
  • RVP $33,049,532.00
  • Revenue This Year
  • ANVS N/A
  • RVP N/A
  • Revenue Next Year
  • ANVS N/A
  • RVP N/A
  • P/E Ratio
  • ANVS N/A
  • RVP N/A
  • Revenue Growth
  • ANVS N/A
  • RVP N/A
  • 52 Week Low
  • ANVS $1.11
  • RVP $0.56
  • 52 Week High
  • ANVS $17.88
  • RVP $1.22
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 56.90
  • RVP 52.69
  • Support Level
  • ANVS $1.42
  • RVP $0.70
  • Resistance Level
  • ANVS $1.75
  • RVP $0.76
  • Average True Range (ATR)
  • ANVS 0.15
  • RVP 0.04
  • MACD
  • ANVS 0.04
  • RVP 0.00
  • Stochastic Oscillator
  • ANVS 84.62
  • RVP 62.55

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: